113 related articles for article (PubMed ID: 3946388)
1. Impact of epidemic cholera in a previously uninfected island population: evaluation of a new seroepidemiologic method.
Harris JR; Holmberg SD; Parker RD; Kay DE; Barrett TJ; Young CR; Levine MM; Blake PA
Am J Epidemiol; 1986 Mar; 123(3):424-30. PubMed ID: 3946388
[TBL] [Abstract][Full Text] [Related]
2. Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae.
Clements ML; Levine MM; Young CR; Black RE; Lim YL; Robins-Browne RM; Craig JP
J Infect Dis; 1982 Apr; 145(4):465-73. PubMed ID: 7069227
[TBL] [Abstract][Full Text] [Related]
3. Serologic studies of naturally acquired infection with Vibrio cholerae serogroup O1 in the United States.
Snyder JD; Allegra DT; Levine MM; Craig JP; Feeley JC; DeWitt WE; Blake PA
J Infect Dis; 1981 Feb; 143(2):182-7. PubMed ID: 7194358
[TBL] [Abstract][Full Text] [Related]
4. Enzyme-linked immunosorbent assay to measure antibodies to purified heat-labile enterotoxins from human and porcine strains of Escherichia coli and to cholera toxin: application in serodiagnosis and seroepidemiology.
Levine MM; Young CR; Black RE; Takeda Y; Finkelstein RA
J Clin Microbiol; 1985 Feb; 21(2):174-9. PubMed ID: 3882744
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
[TBL] [Abstract][Full Text] [Related]
6. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection.
Glass RI; Svennerholm AM; Khan MR; Huda S; Huq MI; Holmgren J
J Infect Dis; 1985 Feb; 151(2):236-42. PubMed ID: 3968450
[TBL] [Abstract][Full Text] [Related]
7. Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli.
Svennerholm AM; Holmgren J; Black R; Levine M; Merson M
J Infect Dis; 1983 Mar; 147(3):514-22. PubMed ID: 6339647
[TBL] [Abstract][Full Text] [Related]
8. Breast milk reduces the risk of illness in children of mothers with cholera: observations from an epidemic of cholera in Guinea-Bissau.
Qureshi K; Mølbak K; Sandström A; Kofoed PE; Rodrigues A; Dias F; Aaby P; Svennerholm AM
Pediatr Infect Dis J; 2006 Dec; 25(12):1163-6. PubMed ID: 17133163
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial and antitoxin responses in the serum and milk of cholera patients.
Majumdar AS; Dutta P; Dutta D; Ghose AC
Infect Immun; 1981 Apr; 32(1):1-8. PubMed ID: 7216479
[TBL] [Abstract][Full Text] [Related]
10. Vibriocidal antibody and antibodies to Vibrio cholerae lipopolysaccharide, cell-bound haemagglutinin and toxin in Thai population.
Chongsa-nguan M; Chaicumpa W; Kalambaheti T; Soejoedi H; Luxananil P; Swasdikosa S; Thanasiri P; Mayurasakorn S
Southeast Asian J Trop Med Public Health; 1986 Dec; 17(4):558-66. PubMed ID: 3576285
[TBL] [Abstract][Full Text] [Related]
11. Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease.
Jertborn M; Svennerholm AM; Holmgren J
J Clin Microbiol; 1986 Aug; 24(2):203-9. PubMed ID: 3528211
[TBL] [Abstract][Full Text] [Related]
12. Oral immunization of dogs with purified cholera toxin, crude cholera toxin, or B subunit: evidence for synergistic protection by antitoxic and antibacterial mechanisms.
Pierce NF; Cray WC; Sacci JB
Infect Immun; 1982 Aug; 37(2):687-94. PubMed ID: 6889574
[TBL] [Abstract][Full Text] [Related]
13. Vibrio cholerae O1 vibriocidal and anti-cholera toxin antibodies in O139 Bengal cholera patients.
Takeda T; Ramamurthy T; Chowdhury AS; Dutta D; Bhattacharya SK; Deb BC; Nair GB; Takeda Y
J Infect; 1994 Sep; 29(2):233-5. PubMed ID: 7806891
[No Abstract] [Full Text] [Related]
14. Antitoxic immunity to cholera in dogs immunized orally with cholera toxin.
Pierce NF; Cray WC; Engel PF
Infect Immun; 1980 Feb; 27(2):632-7. PubMed ID: 7380543
[TBL] [Abstract][Full Text] [Related]
15. Estimation of Vibrio cholerae and Escherichia coli heat-labile enterotoxin by enzyme-linked immunosorbent assay (ELISA).
Kétyi I; Pácsa AS
Acta Microbiol Acad Sci Hung; 1980; 27(1):89-97. PubMed ID: 6998259
[TBL] [Abstract][Full Text] [Related]
16. Antitoxin responses to infections with enterotoxigenic Escherichia coli.
Sack RB; Jacobs B; Mitra R
J Infect Dis; 1974 Mar; 129(3):330-5. PubMed ID: 4593243
[No Abstract] [Full Text] [Related]
17. Duration of serum antitoxin response following Vibrio cholerae infection in North Americans: relevance for seroepidemiology.
Levine MM; Young CR; Hughes TP; O'Donnell S; Black RE; Clements ML; Robins-Browne R; Lim YL
Am J Epidemiol; 1981 Sep; 114(3):348-54. PubMed ID: 7304570
[No Abstract] [Full Text] [Related]
18. [The use of immunoenzyme analysis and the vibriocidal antibody reaction in the serological examination of persons who have had cholera and of those in contact with them].
Mareev VI; Moskvitina EA; Gritsenko AN; Ivanova LV; Efanova EA; Nepomniashchaia NB; Dranov IIu; Boldyr' LA; Griseva LN
Zh Mikrobiol Epidemiol Immunobiol; 1991 Feb; (2):34-6. PubMed ID: 1867031
[TBL] [Abstract][Full Text] [Related]
19. Biological similarity of enterotoxins of Vibrio cholerae serotypes other than type 1 to cholera toxin and Escherichia coli heat-labile enterotoxin.
Lahiri A; Agarwal RK; Sanyal SC
J Med Microbiol; 1982 Nov; 15(4):429-40. PubMed ID: 6757437
[TBL] [Abstract][Full Text] [Related]
20. Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity.
Levine MM; Nalin DR; Craig JP; Hoover D; Bergquist EJ; Waterman D; Holley HP; Hornick RB; Pierce NP; Libonati JP
Trans R Soc Trop Med Hyg; 1979; 73(1):3-9. PubMed ID: 442179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
